000 | 01331 a2200349 4500 | ||
---|---|---|---|
005 | 20250518100159.0 | ||
264 | 0 | _c20201201 | |
008 | 202012s 0 0 eng d | ||
022 | _a1573-7217 | ||
024 | 7 |
_a10.1007/s10549-020-05640-3 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMiyashita, Hirotaka | |
245 | 0 | 0 |
_aBone modifying agents for bone loss in patients with aromatase inhibitor as adjuvant treatment for breast cancer; insights from a network meta-analysis. _h[electronic resource] |
260 |
_bBreast cancer research and treatment _cJun 2020 |
||
300 |
_a279-289 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Meta-Analysis; Review | ||
650 | 0 | 4 |
_aAromatase Inhibitors _xadverse effects |
650 | 0 | 4 |
_aBone Density _xdrug effects |
650 | 0 | 4 |
_aBone Density Conservation Agents _xtherapeutic use |
650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aOsteoporosis _xchemically induced |
650 | 0 | 4 | _aPrognosis |
700 | 1 | _aSatoi, Sera | |
700 | 1 | _aKuno, Toshiki | |
700 | 1 | _aCruz, Christina | |
700 | 1 | _aMalamud, Stephen | |
700 | 1 | _aKim, Se-Min | |
773 | 0 |
_tBreast cancer research and treatment _gvol. 181 _gno. 2 _gp. 279-289 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s10549-020-05640-3 _zAvailable from publisher's website |
999 |
_c30885371 _d30885371 |